Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

JTC in early stage takeover talks with Permira, Warburg Pincus

(Sharecast News) - Fund solutions provider JTC surged on Friday after confirming it has received a preliminary and conditional non-binding takeover proposal from private equity firm Warburg Pincus and a revised offer from Permira. The possible offer from Warburg Pincus follows two earlier non-binding proposals that were unanimously rejected on 5 September and 11 September 2025.

In a statement in response to press speculation, JTC said its board is currently in "early-stage discussions" with Warburg Pincus.

The company also said it was in early-stage talks with Permira about a revised possible takeover offer.

JTC announced last month that it had rejected two proposals from Permira. Since then, it has received and rejected a third offer on 30 August but is now in talks about a fourth revised offer received on 9 September.

Under UK takeover rules, Warburg Pincus has until 10 October to make a firm offer or walk away, while Permira has until 26 September.

At 1555 BST, JTC shares were up 14% at 1,340p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.